Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
Strong topline growth driven by solid performance across key brands.
This tie-up will have no impact on any other brands of the company
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
